Menu

  • Reimbursement
  • Medtronic Academy

    • You’re invested. So are we.

    You’ve invested years in patient care. Our people have done the same for over 25 years, with more than 800,000 patients served.
    We’re here for you with our portfolio, technical expertise, and support where and when it matters.

    Strength in products.

    Our aortic portfolio covers a broad range of indications for abdominal and thoracic procedures in simple to hostile anatomies.

    View the portfolio

    Endurant™ IIs AAA stent graft is a three-piece system that is designed to treat abdominal aortic aneurysms (AAA) in both challenging and straightforward anatomy.

    The standard for EVAR durability
    Endurant™ II-IIs AAA stent graft system

    • Design that uniquely addresses sac regression1–4

    • First and only EVAR system with 10-year global registry data5 and outcomes protection program

    • Over half a million patients treated worldwide6

    More on Endurant™ systems

    alert icon Important safety information

    Risks associated with EVAR procedures may include rupture, conversion to open repair, or secondary procedures.

    This is an image of the Valiant™ thoracic stent graft with the Captivia™ delivery system.

    Deploy durability.7–10
    Valiant™ Captivia™ thoracic stent graft system

    • Maintains continuous seal in a dynamic aortic environment7

    • Five-year outcomes in all DTA pathologies8–10

    • More than 150,000 patients treated worldwide11

    More on Valiant™ Captivia™ system

    alert icon Important safety information

    Risks associated with TEVAR procedures may include rupture, conversion to open repair, or secondary procedures.

    This is an image of the Heli-FX™ EndoAnchor™ implant.

    Reinforced seal.12,13 Redefined outcomes.14–18
    Heli-FX™ EndoAnchor™ system

    • Only commercially available device facilitating endosuture aneurysm repair (ESAR)19

    • Minimizes endoleaks and promotes greater sac regression14,17,18

    • Durable five-year outcomes in challenging patient population14

    More on Heli-FX™ system

    alert icon Important safety information

    Risks may include failure to prevent/correct type I endoleaks, migration, or sac enlargement.

    Strength in evidence.

    The true test of a product is how it performs and delivers results over time. Medtronic maintains the longest-term clinical evidence in the industry, consistently showing successful clinical outcomes across different patient anatomies and the entire aortic portfolio.

    View the data

    Products

    Filter by
    1. Lalys F, Daoudal A, Gindre J, et al. Influencing factors of sac shrinkage after endovascular aneurysm repair. J Vasc Surg. June 2017;65(6):1830–1838.
    2. Makaroun MS, Tuchek M, Massop D, et al. One-year outcomes of the US regulatory trial of the Endurant™ stent graft system. J Vasc Surg. September 2011;54(3):601–608.
    3. Based on internal test report DVR7245 Design Verification Report: Endurant Stent Graft System conducted January–July 2007.
    4. Wakefield TW, Shulkin BL, Fellows EP, Petry NA, Spaulding SA, Stanley, JC. Platelet reactivity in human aortic grafts: a prospective, randomized midterm study of platelet adherence and release products in Dacron and polytetrafluoroethylene conduits. J Vasc Surg. February 1989;9(2):234–243.
    5. Verhagen, et al. The ENGAGE Registry: Ten-Year Outcomes with the Endurant Stent Graft for Endovascular Abdominal Aortic Aneurysm Repair. Presented at: Charing Cross 2023 International Symposium; April 26, 2023; London, UK.
    6. Based on internal Endurant™ patient implant tracking at Medtronic. Data current as of September 2023.
    7. Canaud L, Cathala P, Joyeux F, Branchereau P, Marty-Ané C, Alric P. Improvement in conformability of the latest generation of thoracic stent grafts. J Vasc Surg. 2013 Apr;57(4):1084–9.
    8. Conrad MF, Tuchek J, Freezor R, Bavaria J, White R, Fairman R. Results of the VALOR II trial of the Medtronic Valiant Thoracic Stent Graft. J Vasc Surg. 2017 Aug;66(2):335–342
    9. Bavaria JE, Brinkman WT, Hughes GC, Shah AS, Charlton-Ouw KM, Azizzadeh A, White RA. Five-year outcomes of endovascular repair of complicated acute type B aortic dissections. J Thorac Cardiovasc Surg. 2022 Feb;163(2):539–548.e2.
    10. Patel HJ, Azizzadeh A, Matsumoto AH, Velazquez OC, Rovin JD, Lombardi JV, Khoynezhad A, Dai Y, White RA. Five-Year Outcomes From the United States Pivotal Trial of Valiant Captivia Stent Graft for Blunt Aortic Injury. Ann Thorac Surg. 2020 Sep;110(3):815–820.
    11. Data on file. Internal global finance report, total Valiant Captivia cases.
    12. Melas N, Perdikides T, Saratzis A, Saratzis N, Kiskinis D, Deaton DH. Helical EndoStaples enhance endograft fixation in an experimental model using human cadaveric aortas. J Vasc Surg. June 2012;55(6):1726–1733.
    13. Schlösser FJV, de Vries JPPM, Chaudhuri A. Is it Time to Insert EndoAnchors into Routine EVAR? Eur J Vasc Endovasc Surg. April 2017;53(4):458–459.
    14. Jordan WD, Jr. New Developments From The ANCHOR Registry With Over 5 Years Of Follow-Up Show The Value Of Endoanchors When Used Prophylactically For Certain Indications Prevent Endoleaks And Migration: What Are Those Indications. Presented at VEITH symposium 2021.
    15. Reijnen M. Focus on endosuture/endoanchors : The effect of EndoAnchors on aneurysm sac regression for patients with wide neck abdominal aneurysm from the ANCHOR registry and the HERCULES RCT design. Presented at LINC International Symposium, June 08, 2023; Leipzig, GER, https://www.leipzip-interventional-cource.com/archive/linc-2023/presentations/. Accessed April, 30, 2024.
    16. Tassiopoulos AK, Monastiriotis S, Jordan WD, Muhs BE, Ouriel K, De Vries JP. Predictors of early aortic neck dilatation after endovascular aneurysm repair with EndoAnchors. J Vasc Surg. 2017 Jul;66(1):45–52.
    17. Muhs BE, Jordan W, Ouriel K, Rajaee S, de Vries JP. Matched cohort comparison of endovascular abdominal aortic aneurysm repair with and without EndoAnchors. J Vasc Surg. 2018 Jun;67(6):1699–1707. doi: 10.1016/j.jvs.2017.10.059. Epub 2017 Dec 18. PMID: 29248241.
    18. Reyes Valdivia A, Oikonomou K, Milner R. et al. The effect of EndoAnchors on aneurysm sac regression for patients treated with infrarenal endovascular repair with hostile neck anatomies: a propensity scored analysis. J Endovasc Ther. 2022 Oct 10:15266028221127839. doi: 10.1177/15266028221127839.
    19. Masoomi R, Lancaster E, Robinson A, Hacker E, Krajcer Z, Gupta K. Safety of EndoAnchors in real-world use: A report from the Manufacturer and User Facility Device Experience database. Vascular. 2019;27(5):495–499. doi:10.1177/1708538119844041